BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//DataCutoff//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DataCutoff · $INSM readouts
X-WR-CALDESC:Clinical-trial primary completion dates from ClinicalTrials.go
 v\, refreshed nightly by DataCutoff. Not investment advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05649748-pcd@datacutoff.com
DTSTAMP:20261119T201552Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:Treprostinil Palmitil readout (P2/3) · Insmed Incorporated $INSM
DESCRIPTION:An Extension Study of Treprostinil Palmitil Inhalation Powder (
 TPIP) for Pulmonary Arterial Hypertension (PAH)\n\nPrimary completion date
 : 2026-12-31 (estimated)\nPhase 2/3 · Cardio-Met · Pulmonary Arterial Hy
 pertension\nEnrollment: 91 · Sites: 45\n\nPrimary completion = last parti
 cipant's primary-endpoint data collected\; topline results usually follow 
 weeks to months later. Sponsor-reported\, often an estimate. Not investmen
 t advice.\n\nhttps://datacutoff.com/radar.html?nct=NCT05649748\nhttps://cl
 inicaltrials.gov/study/NCT05649748
URL:https://datacutoff.com/radar.html?nct=NCT05649748
CATEGORIES:Cardio-Met,Phase 2/3
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
